BOT:ASX
Botanix Pharmaceuticals Ltd
0,024 AUD
arrow_upward
+4,35%(+0,0010) 1D
29-май, 16:11:55 GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,02 AUD
High
0,02 AUD
Low
0,02 AUD
Mkt. cap
75,47 млн
Avg. vol.
23,68 млн
Volume
4,81 млн
52-wk high
0,40 AUD
52-wk low
0,02 AUD
EPS
-0,05 AUD
Shares outstanding
2,73 млд
No. of employees
11
Open
0,02 AUD
High
0,02 AUD
Low
0,02 AUD
Mkt. cap
75,47 млн
Avg. vol.
23,68 млн
Volume
4,81 млн
52-wk high
0,40 AUD
52-wk low
0,02 AUD
EPS
-0,05 AUD
Shares outstanding
2,73 млд
No. of employees
11
News stories
From sources across the web
Yahoo Finance
·
23 мүнөт мурун
NYSE Parent Isn't 'Freaked Out' by Hyperliquid—It's Learning From the Crypto Perps Giant
Stock Titan
·
28 мүнөт мурун
Exicure (NASDAQ: XCUR) posts Q1 2026 loss and flags going concern, Nasdaq risks
qz.com
·
6 мүнөт мурун
Michael Reinking on S&P 500 climbing amid Iran uncertainty
Bloomberg
·
6 саат мурун
‘Two Sigma’ S&P Rally Signals Easy Money Has Already Been Made
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
AI content may include mistakes. Learn more